Related Experiment Video
Updated: Feb 1, 2026

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells
Published on: November 1, 2017
CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis
A Nonino1,2, J M Nascimento2,3, C C Mascarenhas1
1Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, DF, Brasil.
Abstract:
Myelofibrosis (MF) is characterized by increased circulating hematopoietic progenitor cells (HPCs), abnormal cytokine levels, and the survival advantage of neoplastic progenitors over their normal counterparts, which leads to progressive disappearance of polyclonal hematopoiesis. CD47 is a surface glycoprotein with many functions, such as acting as a phagocytosis inhibitor of the expressing cell, that is increased in normal hematopoietic stem and progenitor cells mobilized into the blood and several human cancer-initiating cells, such as in acute myeloid leukemia. We compared CD47 expression in hematopoietic stem and progenitor cells of patients with MF and controls and found it to be decreased in progenitors of MF. Exposure of control HPCs to the cytokines transforming growth factor β and stromal-derived factor 1, which are important regulators of hematopoietic stem cell cycling and are overexpressed in patients with MF, did not modulate CD47 expression.
Insights
Myelofibrosis (MF) involves abnormal blood stem cells. Researchers found CD47 protein levels were unexpectedly lower in MF progenitor cells compared to healthy individuals.
Area of Science:
- Hematology
- Immunology
- Cell Biology
Background:
- Myelofibrosis (MF) is a bone marrow disorder characterized by fibrosis, abnormal cytokine levels, and increased circulating hematopoietic progenitor cells (HPCs).
- CD47 is a cell surface protein that inhibits phagocytosis and is often upregulated in cancer stem cells and mobilized normal stem cells.
- The role of CD47 in MF, particularly in relation to progenitor cells, is not well understood.
Purpose of the Study:
- To investigate and compare CD47 expression levels in hematopoietic progenitor cells (HPCs) between patients with myelofibrosis (MF) and healthy controls.
- To determine if cytokines implicated in MF pathogenesis, such as transforming growth factor β (TGF-β) and stromal-derived factor 1 (SDF-1), influence CD47 expression on normal HPCs.
Main Methods:
- Flow cytometry was used to quantify CD47 expression on HPCs isolated from MF patients and healthy donors.
- Control HPCs were cultured with TGF-β and SDF-1 to assess the impact of these cytokines on CD47 expression.
Main Results:
- CD47 expression was found to be significantly decreased on hematopoietic progenitor cells (HPCs) from patients with myelofibrosis (MF) compared to healthy controls.
- Exposure of normal HPCs to TGF-β and SDF-1 did not alter CD47 expression levels.
Conclusions:
- The decreased expression of CD47 on MF progenitor cells suggests a potential role in the disease pathophysiology, contrary to its typical upregulation in other cancers.
- These findings indicate that the dysregulation of CD47 in MF is not directly mediated by the overexpressed cytokines TGF-β and SDF-1.
More Related Videos
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
12:03Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors
Published on: July 8, 2012
Related Concept Videos
Decreasing Function
Decreased Body Temperature
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Cell Specific Gene Expression
Cell Specific Gene Expression
Multipotency of Hematopoietic Stem Cells